PMID- 26058864 OWN - NLM STAT- MEDLINE DCOM- 20151117 LR - 20181113 IS - 1522-1555 (Electronic) IS - 0193-1849 (Print) IS - 0193-1849 (Linking) VI - 309 IP - 4 DP - 2015 Aug 15 TI - Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease. PG - E311-9 LID - 10.1152/ajpendo.00161.2015 [doi] AB - Elevated plasma branched-chain amino acids (BCAA) in the setting of insulin resistance have been relevant in predicting type 2 diabetes mellitus (T2DM) onset, but their role in the etiology of hepatic insulin resistance remains uncertain. We determined the link between BCAA and dysfunctional hepatic tricarboxylic acid (TCA) cycle, which is a central feature of hepatic insulin resistance and nonalcoholic fatty liver disease (NAFLD). Plasma metabolites under basal fasting and euglycemic hyperinsulinemic clamps (insulin stimulation) were measured in 94 human subjects with varying degrees of insulin sensitivity to identify their relationships with insulin resistance. Furthermore, the impact of elevated BCAA on hepatic TCA cycle was determined in a diet-induced mouse model of NAFLD, utilizing targeted metabolomics and nuclear magnetic resonance (NMR)-based metabolic flux analysis. Insulin stimulation revealed robust relationships between human plasma BCAA and indices of insulin resistance, indicating chronic metabolic overload from BCAA. Human plasma BCAA and long-chain acylcarnitines also showed a positive correlation, suggesting modulation of mitochondrial metabolism by BCAA. Concurrently, mice with NAFLD failed to optimally induce hepatic mTORC1, plasma ketones, and hepatic long-chain acylcarnitines, following acute elevation of plasma BCAA. Furthermore, elevated BCAA failed to induce multiple fluxes through hepatic TCA cycle in mice with NAFLD. Our data suggest that BCAA are essential to mediate efficient channeling of carbon substrates for oxidation through mitochondrial TCA cycle. Impairment of BCAA-mediated upregulation of the TCA cycle could be a significant contributor to mitochondrial dysfunction in NAFLD. FAU - Sunny, Nishanth E AU - Sunny NE AD - Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and nishanth.sunny@medicine.ufl.edu. FAU - Kalavalapalli, Srilaxmi AU - Kalavalapalli S AD - Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and. FAU - Bril, Fernando AU - Bril F AD - Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and. FAU - Garrett, Timothy J AU - Garrett TJ AD - Department of Pathology, University of Florida, Gainesville, Florida; FAU - Nautiyal, Manisha AU - Nautiyal M AD - Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and. FAU - Mathew, Justin T AU - Mathew JT AD - Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and. FAU - Williams, Caroline M AU - Williams CM AD - Department of Integrative Biology, University of California, Berkeley, California. FAU - Cusi, Kenneth AU - Cusi K AD - Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, and Division of Endocrinology, Diabetes, and Metabolism, Malcom Randall Veterans Administration Medical Center (VAMC), Gainesville, Florida; Division of Diabetes, University of Texas Health Science Center at San Antonio, and Division of Diabetes, Audie L. Murphy VAMC, San Antonio, Texas; and. LA - eng GR - UL1-TR-000064/TR/NCATS NIH HHS/United States GR - P30 AG028740/AG/NIA NIH HHS/United States GR - U24 DK097209/DK/NIDDK NIH HHS/United States GR - UL1 TR001427/TR/NCATS NIH HHS/United States GR - U24 DK-097209/DK/NIDDK NIH HHS/United States PT - Clinical Trial PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20150609 PL - United States TA - Am J Physiol Endocrinol Metab JT - American journal of physiology. Endocrinology and metabolism JID - 100901226 RN - 0 (Amino Acids, Branched-Chain) RN - 0 (Insulin) SB - IM MH - Amino Acids, Branched-Chain/*metabolism/pharmacology MH - Animals MH - Citric Acid Cycle/drug effects MH - Female MH - Glucose Clamp Technique MH - Humans MH - Insulin/pharmacology MH - Insulin Resistance MH - Lipid Metabolism/drug effects MH - Liver/*metabolism/pathology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Middle Aged MH - Mitochondria, Liver/*metabolism/pathology MH - Non-alcoholic Fatty Liver Disease/*metabolism/pathology MH - Receptor Cross-Talk PMC - PMC4537921 OTO - NOTNLM OT - branched chain amino acids OT - insulin resistance OT - mitochondrial metabolism OT - nonalcoholic fatty liver disease EDAT- 2015/06/11 06:00 MHDA- 2015/11/18 06:00 PMCR- 2016/08/15 CRDT- 2015/06/11 06:00 PHST- 2015/04/06 00:00 [received] PHST- 2015/06/04 00:00 [accepted] PHST- 2015/06/11 06:00 [entrez] PHST- 2015/06/11 06:00 [pubmed] PHST- 2015/11/18 06:00 [medline] PHST- 2016/08/15 00:00 [pmc-release] AID - ajpendo.00161.2015 [pii] AID - E-00161-2015 [pii] AID - 10.1152/ajpendo.00161.2015 [doi] PST - ppublish SO - Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E311-9. doi: 10.1152/ajpendo.00161.2015. Epub 2015 Jun 9.